New hope for patients with rare bladder cancer to keep their bladder
NCT ID NCT06417190
Summary
This study is testing whether a combination of chemotherapy, immunotherapy, and radiation can effectively treat a rare form of muscle-invasive bladder cancer while allowing patients to keep their bladder. The treatment approach will be given to 20 participants with this specific cancer type and compared to historical data from patients with more common bladder cancer. The main goal is to see if this bladder-preserving strategy is a practical option that can be delivered quickly enough to prevent the cancer from spreading.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUSCLE-INVASIVE BLADDER CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cedars Sinai Medical Center
RECRUITINGLos Angeles, California, 90048, United States
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.